Fig. 2From: Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)Gambogic acid (GA) induced pancreatic cancer S-phase cell cycle arrest. Pancreatic cancer cells were treated with 0.0, 0.5, 1.0, and 2.0 μM GA for 24 h, respectively, and the cell cycle was evaluated using flow cytometry. a PANC-1 cells; (b) BxPC-3 cells; (c) MIA PaCa-2 cells; (d) SW1990 cellsBack to article page